We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

126 hedge funds and large institutions have $1.05B invested in Abiomed Inc in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital invested

Capital invested by funds: $743M → $1.05B (+$303M)

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

3% more funds holding

Funds holding: 122 → 126 (+4)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

18% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 49

83% less call options, than puts

Call options by funds: $898K | Put options by funds: $5.34M

Holders
126
Holders Change
+4
Holders Change %
+3.28%
% of All Funds
3.66%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
20
Increased
40
Reduced
49
Closed
16
Calls
$898K
Puts
$5.34M
Net Calls
-$4.44M
Net Calls Change
-$2.8M

Top Buyers

1
CAM
Cortina Asset Management
Wisconsin
+$6.93M
2
CCM
Cupps Capital Management
Illinois
+$6.22M
3
GCM
Geneva Capital Management
Wisconsin
+$5.42M
4
William Blair & Company
William Blair & Company
Illinois
+$4.49M
5
NIP
Nicholas Investment Partners
California
+$3.12M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$4.48M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.03M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.55M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.91M
5
NCGI
Next Century Growth Investors
Minnesota
-$2.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
126
Marshall Wace North America
New York
– -$1.41M -73,810 Closed
ARTA
127
A.R.T. Advisors
New York
– -$1.29M -67,485 Closed
Zurich Cantonal Bank
128
Zurich Cantonal Bank
Switzerland
– -$1.14M -60,000 Closed
SCM
129
Stevens Capital Management
Pennsylvania
– -$904K -47,409 Closed
First Trust Advisors
130
First Trust Advisors
Illinois
– -$670K -35,167 Closed
USAA
131
United Services Automobile Association
Texas
– -$524K -27,500 Closed
ProShare Advisors
132
ProShare Advisors
Maryland
– -$481K -25,225 Closed
Citadel Advisors
133
Citadel Advisors
Florida
– -$467K -18,906 -100%
Tudor Investment Corp
134
Tudor Investment Corp
Connecticut
– -$305K -16,000 Closed
SCA
135
SAC Capital Advisors
Connecticut
– -$295K -15,457 Closed
Two Sigma Investments
136
Two Sigma Investments
New York
– -$262K -13,746 Closed
T. Rowe Price Associates
137
T. Rowe Price Associates
Maryland
– -$235K -12,300 Closed
SG Americas Securities
138
SG Americas Securities
New York
– -$139K -7,307 Closed
FANJ
139
Financial Architects (New Jersey)
New Jersey
– -$76K -4,000 Closed
TRCT
140
Tower Research Capital (TRC)
New York
– -$59K -3,100 Closed
SFSIG
141
San Francisco Sentry Investment Group
California
– -$38K -2,000 Closed
Creative Planning
142
Creative Planning
Kansas
– -$2K -100 Closed
2 3 4 5
6

ABMD Hedge Fund Activity: Q4 2013 in Review

126 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2013, worth a combined $1.05B — up 41% from $743M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ABMD positions and 16 closed out — a net gain of 4 holders — while 40 added to existing stakes and 49 trimmed.

The largest buyer was Cortina Asset Management, opening a new position worth an estimated $6.93M. The largest seller was Renaissance Technologies, cutting an estimated $4.48M.

  • 126 institutional investors held Abiomed Inc (ABMD) as of Q4 2013, up from 122 in Q3 2013.
  • Funds reported $1.05B of Abiomed Inc stock for Q4 2013, up 41% quarter-over-quarter.
  • 20 funds opened new Abiomed Inc positions in Q4 2013 and 16 closed out, a net change of +4 holders.
  • The largest Abiomed Inc buyer in Q4 2013 was Cortina Asset Management, an estimated $6.93M added.
  • The largest Abiomed Inc seller in Q4 2013 was Renaissance Technologies, an estimated $4.48M sold.

Based on aggregated 13F filings for Q4 2013.